The stem cell transcription factor Sox2 is widely recognized for its many roles during normal development and cancer. Over the last several years, it has become increasingly evident that Sox2 dosage plays critical roles in both normal and malignant cells. The work described in this review indicates that the dosage of Sox2 influences cell fate decisions made during normal mammalian development, as well as cell fate decisions in cancer, including those that influence the tumor cell of origin and progression of the cancer. Equally important, Sox2 dosage is a key determinant in the proliferation of both normal cells and tumor cells, where proliferation is restricted in Sox2 cells. Collectively, the studies reviewed here indicate that tumor cells utilize the fundamental effects of Sox2 dosage to suit their own needs. Finally, we speculate that elevated expression of Sox2 helps establish and maintain tumor dormancy in Sox2-positive cancers.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6662612 | PMC |
| http://dx.doi.org/10.1002/jcp.28610 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Influence of choline and follistatin supplementation during in vitro bovine oocyte maturation on oocyte competence and blastocyst development.
Zygote
August 2024
USDA, Agricultural Research Service, U.S. Meat Animal Research Center, Clay Center, NE, USA.
Article Synopsis
- The study examines the effects of metabolite supplementation, specifically choline and follistatin, during in vitro maturation (IVM) of bovine oocytes on blastocyst quality.
- It hypothesizes that combining choline with follistatin will enhance oocyte quality and early embryonic development, leading to improved outcomes.
- Initial findings suggest that while choline at high concentrations positively influences blastocyst quality, the interaction with follistatin requires further research to fully understand its impact on embryonic and fetal development.
A multi-institutional study to investigate the sparing effect after whole brain electron FLASH in mice: Reproducibility and temporal evolution of functional, electrophysiological, and neurogenic endpoints.
Radiother Oncol
December 2024
Department of Radiation Oncology, University of California, Irvine, CA 92697, USA. Electronic address:
Background And Purpose: Ultra-high dose-rate radiotherapy (FLASH) has been shown to mitigate normal tissue toxicities associated with conventional dose rate radiotherapy (CONV) without compromising tumor killing in preclinical models. A prominent challenge in preclinical radiation research, including FLASH, is validating both the physical dosimetry and the biological effects across multiple institutions.
Materials And Methods: We previously demonstrated dosimetric reproducibility of two different electron FLASH devices at separate institutions using standardized phantoms and dosimeters.
[Experimental study on treatment of retinitis pigmentosa by inducing Müller cell reprogramming with Lycii Fructus and Salviae Miltiorrhizae Radix et Rhizoma].
Zhongguo Zhong Yao Za Zhi
June 2024
Key Laboratory of Traditional Chinese Medicine for Prevention and Treatment of Eye, Ear, Nose and Throat Diseases, Hunan University of Chinese Medicine Changsha 410208, China.
This study aims to explore the effect of Lycii Fructus and Salviae Miltiorrhizae Radix et Rhizoma(LFSMR), a drug pair possesses the function of nourishing Yin, promoting blood circulation, and brightening the eyes, in treating retinitis pigmentosa(RP)by inhibiting the gliosis of Müller cells(MCs) and inducing their reprogramming and differentiation into various types of retinal nerve cells. Twelve C57 mice were used as the normal control group, and 48 transgenic RP(rd10) mice were randomly divided into the model group, positive control group, and low and high dose LFSMR groups, with 12 mice in each group. HE staining was used to detect pathological changes in the retina, and an electroretinogram was used to detect retinal function.
View Article and Find Full Text PDFCombination of monensin and erlotinib synergistically inhibited the growth and cancer stem cell properties of triple-negative breast cancer by simultaneously inhibiting EGFR and PI3K signaling pathways.
Breast Cancer Res Treat
September 2024
Engineering Center of Innovativennovative Veterinary Drugs, Center for Veterinary Drug Research and Evaluation, Nanjing Agricultural University, 1 Weigang, Nanjing, 210095, China.
Background: Cancer stem cells (CSCs) in triple-negative breast cancer (TNBC) are recognized as a highly challenging subset of cells, renowned for their heightened propensity for relapse and unfavorable prognosis. Monensin, an ionophoric antibiotic, has been reported to exhibit significant therapeutic efficacy against various cancers, especially CSCs. Erlotinib is classified as one of the EGFR-TKIs and has been previously identified as a promising therapeutic target for TNBC.
View Article and Find Full Text PDFTargeting resistant breast cancer stem cells in a three-dimensional culture model with oleuropein encapsulated in methacrylated alginate microparticles.
Daru
December 2024
Department of Stem Cell Sciences, Graduate School of Health Sciences, Hacettepe University, Ankara, Turkey.
Article Synopsis
- Cancer stem cells (CSCs) are crucial in tumor development and resistance to treatments, and oleuropein, a compound from olive leaves, has promising anti-cancer properties by killing CSCs and enhancing chemotherapy effectiveness.
- The study focuses on targeting resistant CSCs using oleuropein encapsulated in methacrylated alginate (OLE-mALG) within a realistic tumor environment to improve treatment outcomes.
- Methods included creating a 3D breast cancer model and testing this OLE-mALG for its ability to reduce CSC viability and induce apoptosis, ensuring effective delivery and performance of the compound.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!